Monday, 23 May 2016

Leading pharmaceutical service provider WuXi App Tec enters the European market, acquires Crelux in Germany

Leveraging its presence in China and the USA, WuXi App Tec has announced its entry into the European market, having made the acquisition of Munich-based Crelux. The transaction represents a significant step in the company´s global expansion strategy.

Headquartered in Shanghai, WuXi AppTec is a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries. Crelux is a leading manufacturer and provider of high-quality proteins and protein-structure analysis and an established partner of the global pharmaceutical, biotech and diagnostic industry.

WuXi App Tec has been a client of Orth Kluth since late 2015 and receives legal advice and counsel across many practice areas including corporate law/mergers and acquisitions, antitrust and competition law, public law (particularly EU laws on state aid), real estate and labor law and contract as well as intellectual property law.